# Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-ii-trial-of-coq10-for-als-finds-insufficient-evidence-to-justify-phase-iii/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Petra Kaufmann,John L.P. Thompson,Gilberto Levy,Richard Buchsbaum,Jeremy M. Shefner,Lisa S. Krivickas,Jonathan Katz,Yvonne D. Rollins,Richard J. Barohn,Carlayne E. Jackson,Ezgi Tiryaki,Catherine Lomen‐Hoerth,Carmel Armon,Rup Tandan,Stacy A. Rudnicki,Kourosh Rezania,Robert Sufit,Alan Pestronk,Steven Novella,Terry Heiman‐Patterson,Edward J. Kasarskis,Erik P. Pioro,Jacqueline Montes,Rachel Arbing,Darleen Vecchio,Alexandra I. Barsdorf,Hiroshi Mitsumoto,Bruce Levin |
| Citations | 235 |
| DOI | 10.1002/ana.21743 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/2854625 |
| OpenAlex ID | https://openalex.org/W2067106492 |
| PMID | 19743457 |
| Type | article |
| Year | 2009 |

## Paper authors

- [Erik P. Pioro](https://scholariq.org/researchers/erik-p-pioro/)

## Paper journal

- [Annals of Neurology](https://scholariq.org/journals/annals-of-neurology/)

## Paper primary topic

- [Coenzyme Q10 studies and effects](https://scholariq.org/topics/coenzyme-q10-studies-and-effects/)

## Paper topics

- [Coenzyme Q10 studies and effects](https://scholariq.org/topics/coenzyme-q10-studies-and-effects/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Genomics, phytochemicals, and oxidative stress](https://scholariq.org/topics/genomics-phytochemicals-and-oxidative-stress/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.